This page shows the publications co-authored by Jeffrey Popma and Andrew Selwyn.
Roundtable discussion: therapeutic challenges and deficiencies. Am J Cardiol. 2001 Oct 18; 88(8A):42K-43K.
Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol. 2001 Jul 01; 88(1):5-9.
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv. 2001 Apr; 52(4):425-32.
Lipid-lowering therapy after coronary revascularization. Am J Cardiol. 2000 Aug 24; 86(4B):18H-28H.
Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol. 2001 Sep 01; 88(5):493-6.
The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000 Aug 24; 86(4B):6H-11H.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.